These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31321991)

  • 1. Putting the spotlight on CRISPR.
    Lake F
    Biotechniques; 2019 Aug; 67(2):41. PubMed ID: 31321991
    [No Abstract]   [Full Text] [Related]  

  • 2. Putting the spotlight on: CRISPR.
    Lake F
    Biotechniques; 2019 Oct; 67(4):150-152. PubMed ID: 31526035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas systems for genome engineering and investigation.
    Concordet JP; Giovannangeli C
    Methods; 2017 May; 121-122():1-2. PubMed ID: 28645537
    [No Abstract]   [Full Text] [Related]  

  • 9. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 11. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unleashing CRISPR on Cancer.
    N Engl J Med; 2023 Jun; 388(25):e78. PubMed ID: 37342929
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Screens: Better Together.
    Pruett-Miller SM
    CRISPR J; 2020 Feb; 3(1):12-14. PubMed ID: 32091251
    [No Abstract]   [Full Text] [Related]  

  • 16. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 17. The New Genetic Frontier: CRISPR-Cas9?
    Hansen K
    S D Med; 2017 Jun; 70(6):245. PubMed ID: 28813758
    [No Abstract]   [Full Text] [Related]  

  • 18. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR: gene editing is just the beginning.
    Ledford H
    Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
    [No Abstract]   [Full Text] [Related]  

  • 20. A CRISPR Way to Identify Cancer Targets.
    Hahn WC
    N Engl J Med; 2019 Jun; 380(25):2475-2477. PubMed ID: 31216404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.